HIV-1 DNA vaccine efficacy is enhanced by coadministration with plasmid encoding IFN-α

Journal of Virological Methods

Volumn 146, Issue 1-2, 2007, Pages 266-273

  Jiang, Wenzheng ^a,b   Ren, Lisong ^c   Jin, Ningyi ^a  

^a The Eleventh Institute   (China)

^b EAST CHINA NORMAL UNIVERSITY   (China)

^c JILIN UNIVERSITY   (China)

Author keywords

Coadministration; DNA vaccine; HIV 1; IFN

Indexed keywords

ALPHA INTERFERON; DNA VACCINE; GAG PROTEIN; GLYCOPROTEIN GP 120; PLASMID VECTOR;

ADJUVANT THERAPY; ANIMAL CELL; ANTIBODY RESPONSE; ARTICLE; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOTOXICITY; DNA IMMUNIZATION; DRUG EFFICACY; FEMALE; GENE; HELA CELL; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMORAL IMMUNITY; IMMUNOGENICITY; INOCULATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SPLEEN; T LYMPHOCYTE; WESTERN BLOTTING;

ADJUVANTS, IMMUNOLOGIC; AIDS VACCINES; ANIMALS; CYTOTOXICITY, IMMUNOLOGIC; GENE PRODUCTS, GAG; GENETIC VECTORS; HIV ANTIBODIES; HIV ENVELOPE PROTEIN GP120; HIV INFECTIONS; HIV-1; HUMANS; INTERFERON-ALPHA; MICE; MICE, INBRED BALB C; PLASMIDS; T-LYMPHOCYTE SUBSETS; T-LYMPHOCYTES, CYTOTOXIC; VACCINES, DNA;

EUKARYOTA; HUMAN IMMUNODEFICIENCY VIRUS 1; MURINAE; MUS;

EID: 35648946747     PISSN: 01660934     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jviromet.2007.07.016     Document Type: Article

References (40)

1. Aldhous M.C., Watret K.C., Mok J.Y., Bird A.G., and Froebel K.S. Cytotoxic T lymphocyte activity and CD8 subpopulations in children at risk of HIV infection. Clin. Exp. Immunol. 97 (1994) 61-67
2. Almond N.M., and Heeney J.L. AIDS vaccine development in primate models. AIDS 12 (1998) 133-140
3. Asselin-Paturel C., Brizard G., Chemin K., Boonstra A., O'Garra A., Vicari A., and Trinchieri G. Type I interferon dependence of plasmacytoid dendritic cell activation and migration. J. Exp. Med. 201 (2005) 1157-1167
4. Babiuk L.A. Broadening the approaches to developing more effective vaccines. Vaccine 17 (1999) 1587-1595
5. Belardelli F. Role of interferons and other cytokines in the regulation of the immune response. APMIS 103 (1995) 161-179
6. Bogdan C. The function of type I interferons in antimicrobial immunity. Curr. Opin. Immunol. 12 (2000) 419-424
7. Bolesta E., Kowalczyk A., Wierzbicki A., Eppolito C., Kaneko Y., Takiguchi M., Stamatatos L., Shrikant P.A., and Kozbor D. Increased level and longevity of protective immune responses induced by DNA vaccine expressing the HIV-1 Env glycoprotein when combined with IL-21 and IL-15 gene delivery. J. Immunol. 177 (2006) 177-191
8. Boyle J.S., Silva A., Brady J.L., and Lew A.M. DNA immunization: induction of higher avidity antibody and effect of route on T cell cytotoxicity. Proc. Natl. Acad. Sci. U. S. A. 94 (1997) 14626-14631
9. Burton D.R. A vaccine for HIV type 1: the antibody perspective. Proc. Natl. Acad. Sci. U. S. A. 94 (1997) 10018-10023
10. Catanzaro A.T., Roederer M., Koup R.A., Bailer R.T., Enama M.E., Nason M.C., Martin J.E., Rucker S., Andrews C.A., Gomez P.L., Mascola J.R., Nabel G.J., and Graham B.S. Phase I clinical evaluation of a six-plasmid multiclade HIV-1 DNA candidate vaccine. Vaccine 25 (2007) 4085-4092
11. Cohen A.D., Boyer J.D., and Weiner D.B. Modulating the immune response to genetic immunization. FASEB J. 12 (1998) 1611-1626
12. Cull V.S., Broomfield S., Bartlett E.J., Brekalo N.L., and James C.M. Coimmunisation with type I IFN genes enhances protective immunity against cytomegalovirus and myocarditis in gB DNA-vaccinated mice. Gene. Ther. 9 (2002) 1369-1378
13. Deshmukh T.M., Lole K.S., Tripathy A.S., and Arankalle V.A. Immunogenicity of candidate hepatitis E virus DNA vaccine expressing complete and truncated ORF2 in mice. Vaccine 25 (2007) 4350-4360
14. Donnelly J.J., Ulmer J.B., Shiver J.W., and Liu M.A. DNA vaccines. Annu. Rev. Immunol. 15 (1997) 617-621
15. Farrar J.D., and Murphy K.M. Type I interferons and T helper development. Immunol. Today 21 (2000) 484-489
16. Fynan E.F., Webster R.G., Fuller D.H., Haynes J.R., Santoro J.C., and Robinson H.L. DNA vaccines: a novel approach to immunization. Int. J. Immunopharmacol. 17 (1995) 79-83
17. Gabriele L., Borghi P., Rozera C., Sestili P., Andreotti M., Guarini A., Montefusco E., Foa R., and Belardelli F. IFN-α promotes the rapid differentiation of monocytes from patients with chronic myeloid leukemia into activated dendritic cells tuned to undergo full maturation after LPS treatment. Blood 103 (2004) 980-987
18. Graham B.S., Koup R.A., Roederer M., Bailer R.T., Enama M.E., Moodie Z., Martin J.E., McCluskey M.M., Chakrabarti B.K., Lamoreaux L., Andrews C.A., Gomez P.L., Mascola J.R., and Nabel G.J. Phase 1 safety and immunogenicity evaluation of a multiclade HIV-1 DNA candidate vaccine. J. Infect. Dis. 194 (2006) 1650-1660
19. Jiang W.Z., Jin N.Y., Cui S.F., Li Z.J., Zhang L.S., Wang H.W., and Han W.Y. Enhancing immune responses against HIV-1 DNA vaccine by coinoculating IL-6 expression vector. J. Virol. Methods 136 (2006) 1-7
20. CN gp120 and IL-2. J. Virol. Methods 130 (2005) 95-101
21. CN in Pichia pastoris. J. Virol. Methods 123 (2005) 35-40
22. Kim J.J., Simbiri K.A., Sin J.I., Dang K., Oh J., Dentchev T., Lee D., Nottingham L.K., Chalian A.A., McCallus D., Ciccarelli R., Agadjanyan M.G., and Weiner D.B. Cytokine molecular adjuvants modulate immune responses induced by DNA vaccine constructs for HIV-1 and SIV. J. Interferon Cytokine Res. 19 (1999) 77-84
23. Kim J.J., Trivedi N.N., Nottingham L.K., Morrison L., Tsai A., Hu Y., Mahalingam S., Dang K., Ahn L., Doyle N.K., Wilson D.M., Chattergoon M.A., Chalian A.A., Boyer J.D., Agadjanyan M.G., and Weiner D.B. Modulation of amplitude and direction of in vivo immune responses by co-administration of cytokine gene expression cassettes with DNA immunogens. Eur. J. Immunol. 28 (1998) 1089-1103
24. Klinman D.M., Yamshchikov G., and Ishigatsubo Y. Contribution of CpG motifs to the immunogenicity of DNA vaccines. J. Immunol. 158 (1997) 3635-3639
25. Le Bon A., Etchart N., Rossmann C., Ashton M., Hou S., Gewert D., Borrow P., and Tough D.F. Cross-priming of CD8+ T cells stimulated by virus-induced type I interferon. Nat. Immunol. 4 (2003) 1009-1015
26. McAdam S., Kaleebu P., Krausa P., Goulder P., French N., Collin B., and Blanchard T. Cross-clade recognition of p55 by cytotoxic T lymphocytes in HIV-1 infection. AIDS 12 (1998) 571-579
27. Min W., Lillehoj H.S., Burnside J., Weining K.C., Staeheli P., and Zhu J.J. Adjuvant effects of IL-1β, IL-2, IL-8, IL-15, IFN-α. IFN-γ TGF-β4 and lymphotactin on DNA vaccination against Eimeria acervulina. Vaccine 20 (2002) 267-274
28. Musey L., Hughes J., Schacker T., Shea T., Corey L., and McElrath M.J. Cytotoxic-T-cell responses, viral load, and disease progression in early human immunodeficiency virus type 1 infection. N. Engl. J. Med. 337 (1997) 1267-1274
29. Nimal S., Heath A.W., and Thomas M.S. Enhancement of immune responses to an HIV gp120 DNA vaccine by fusion to TNF alpha cDNA. Vaccine 24 (2006) 3298-3308
30. Noisakran S., Campbell I.L., and Carr D.J.J. Ectopic expression of DNA encoding IFN-a1 in the cornea protects mice from herpes simplex virus type 1-induced encephalitis. J. Immunol. 162 (1999) 4184-4190
31. Qiu J.T., Song R., Dettenhofer M., Tian C., August T., Felber B.K., Pavlakis G.N., and Yu X.F. Evaluation of novel human immunodeficiency virus type 1 Gag DNA vaccines for protein expression in mammalian cells and induction of immune responses. J. Virol. 73 (1999) 9145-9152
32. Remoli M.E., Giacomini E., Lutfalla G., Dondi E., Orefici G., Battistini A., Uze G., Pellegrini S., and Coccia E.M. Selective expression of type I interferon genes in human dendritic cells infected with Mycobacterium tuberculosis. J. Immunol. 169 (2002) 366-374
33. Sato Y., Roman M., Tighe H., Lee D., Corr M., Nguyen M.D., Silverman G.J., Lotz M., Carson D.A., and Raz E. Immunostimulatory DNA sequences necessary for effective intradermal gene immunization. Science 273 (1996) 352-354
34. Scandella C.J., Kilpatrick J., Lidster W., Parker C., Moore J.P., Moore G.K., Mann K.A., Brown P., Coates S., Chapman B., Masiarz R.R., Steimer K.S., and Haigwood N.L. Non-affinity purification of recombinant gp120 for use in AIDS vaccine development. AIDS Res. Hum. Retroviruses 9 (1993) 1233-1244
35. Tang D.C., DeVit M., and Johnston S.A. Genegic immunization is a simple method for eliciting an immune response. Nature 356 (1992) 152-154
36. Tighe H., Takabayashi K., Schwartz D., Marsden R., Beck L., Corbeil J., Richman D.D., Eiden J.J.J., Spiegelberg H.L., and Raz E. Conjugation of protein to immunostimulatory DNA results in a rapid, long-lasting and potent induction of cell-mediated and humoral immunity. Eur. J. Immunol. 30 (2000) 1939-1947
37. Tough D.F. Type I interferon as a link between innate and adaptive immunity through dendritic cell stimulation. Leuk. Lymphoma 45 (2004) 257-264
38. Tsuji T., Hamajima K., Fukushima J., Xin K.Q., Ishii N., Aoki I., Ishigatsubo Y., Tani K., Kawamoto S., Nitta Y., Miyazaki J., Koff W.C., Okubo T., and Okuda K. Enhancement of cell-mediated immunity against HIV-1 induced by coinoculation of plasmid-encoded HIV-1 antigen with plasmid expressing IL-12. J. Immunol. 158 (1997) 4008-4013
39. Ulmer J.B., Deck R.R., Dewitt C.M., Donnhly J.I., and Liu M.A. Generation of MHC class I-restricted cytotoxic T lymphocytes by expession of a viral protein in muscle cells: antigen presentation by non-muscle cells. Immunology 89 (1996) 59-67
40. Yankauckas M.A., Morrow J.E., Parker S.E., Abai A., Rhodes G.H., Dwarki V.J., and Gromkowski S.H. Long-term anti-nucleoprotein cellular and humoral immunity is induced by intramuscular injection of plasmid DNA containing NP gene. DNA Cell Biol. 12 (1993) 771-776